A key opinion leader discusses how the management of multiple sclerosis (MS) has changed during the COVID-19 (coronavirus disease 2019) pandemic, with special consideration to DMT prescription and laboratory monitoring.
A key opinion leader discusses how the management of multiple sclerosis (MS) has changed during the COVID-19 (coronavirus disease 2019) pandemic, with special consideration to DMT prescription and laboratory monitoring.